These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8915710

  • 1. Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by retinoic acid in human epithelial and fibroblast tumor cell lines.
    Zoumpourlis V, Ergazaki M, Spandidos DA.
    Int J Biol Markers; 1996; 11(3):153-8. PubMed ID: 8915710
    [Abstract] [Full Text] [Related]

  • 2. Mitomycin C stimulates the expression of human immunodeficiency virus long terminal repeat sequences in rat and human fibroblasts.
    Zoumpourlis V, Spandidos DA.
    Biochem Pharmacol; 1993 Jul 06; 46(1):178-81. PubMed ID: 8347129
    [Abstract] [Full Text] [Related]

  • 3. Hexamethylene bisacetamide stimulates the expression of human immunodeficiency virus long terminal repeat sequences in rat and human fibroblasts.
    Zoumpourlis V, Spandidos DA.
    Anticancer Drugs; 1992 Apr 06; 3(2):163-7. PubMed ID: 1525395
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hexamethylene bisacetamide and cis-platin stimulate the expression from the HIV-1 long terminal repeat sequence in human MCF-7 cells.
    Tsatsanis C, Tsiriyotis C, Spandidos DA.
    In Vivo; 1992 Apr 06; 6(2):145-9. PubMed ID: 1525334
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by tumor necrosis factor.
    Zoumpourlis V, Eliopoulos AG, Spandidos DA.
    Anticancer Res; 1992 Apr 06; 12(6B):2065-8. PubMed ID: 1295450
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin stimulates the expression from the human immunodeficiency virus long terminal repeat sequences in human fibroblasts.
    Zoumpourlis V, Patsilinacos P, Kotsinas A, Maurer HR, Lenas P, Spandidos DA.
    Anticancer Drugs; 1990 Oct 06; 1(1):55-8. PubMed ID: 2131039
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin stimulates transcription from the human immunodeficiency virus long terminal repeat sequences.
    Zoumpourlis V, Kerr DJ, Spandidos DA.
    Cancer Lett; 1991 Feb 06; 56(2):181-5. PubMed ID: 1705476
    [Abstract] [Full Text] [Related]

  • 12. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM, Sweet MJ, Ross IL, Hume DA.
    J Virol; 1993 Dec 06; 67(12):6956-64. PubMed ID: 8230418
    [Abstract] [Full Text] [Related]

  • 13. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity.
    Maio JJ, Brown FL.
    J Cell Physiol; 1991 Dec 06; 149(3):548-59. PubMed ID: 1660486
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May 06; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 16. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW, Talmage DA, Viglianti GA.
    J Virol; 1994 Oct 06; 68(10):6598-604. PubMed ID: 8083995
    [Abstract] [Full Text] [Related]

  • 17. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines.
    Maitra RK, Ahmad N, Holland SM, Venkatesan S.
    Virology; 1991 Jun 06; 182(2):522-33. PubMed ID: 2024488
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter.
    Towers G, Harris J, Lang G, Collins MK, Latchman DS.
    AIDS; 1995 Feb 06; 9(2):129-36. PubMed ID: 7718183
    [Abstract] [Full Text] [Related]

  • 19. The kinetics of HIV-1 long terminal repeat transcriptional activation resemble those of hsp70 promoter in heat-shock treated HeLa cells.
    Kretz-Remy C, Arrigo AP.
    FEBS Lett; 1994 Sep 05; 351(2):191-6. PubMed ID: 8082763
    [Abstract] [Full Text] [Related]

  • 20. A palindromic element in the human immunodeficiency virus long terminal repeat binds retinoic acid receptors and can confer retinoic acid responsiveness on a heterologous promoter.
    Orchard K, Lang G, Harris J, Collins M, Latchman D.
    J Acquir Immune Defic Syndr (1988); 1993 May 05; 6(5):440-5. PubMed ID: 8387109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.